|
|
Volumn 119, Issue 10, 2012, Pages 2125-2132
|
|
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOCINOLONE ACETONIDE;
ARTICLE;
CATARACT;
CATARACT EXTRACTION;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC MACULAR EDEMA;
DIABETIC RETINOPATHY;
DOUBLE BLIND PROCEDURE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
GLAUCOMA;
HUMAN;
INCIDENCE;
LOW DRUG DOSE;
LOW LEVEL LASER THERAPY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PSEUDOPHAKIA;
RANDOMIZED CONTROLLED TRIAL;
RETINA FOVEA;
SCORING SYSTEM;
VISION;
ANTIHYPERTENSIVE AGENTS;
CATARACT;
DIABETIC RETINOPATHY;
DOUBLE-BLIND METHOD;
DRUG IMPLANTS;
FLUOCINOLONE ACETONIDE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
GLAUCOMA;
GLUCOCORTICOIDS;
HUMANS;
MACULAR EDEMA;
PHACOEMULSIFICATION;
TOMOGRAPHY, OPTICAL COHERENCE;
TRABECULECTOMY;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITREOUS BODY;
|
|
EID: 84867099927
PISSN: 01616420
EISSN: 15494713
Source Type: Journal
DOI: 10.1016/j.ophtha.2012.04.030 Document Type: Article |
|
Times cited : (428)
|
|
References (4)
|
